These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 104537)

  • 21. Role of Dapsone in chemotherapy of leprosy--a comparison of responses to therapy in two cohorts in 1960s and 1970s.
    Reddy BN; Neelan PN
    Indian J Lepr; 1984; 56(4):912-8. PubMed ID: 6398345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leprosy.
    Browne SG
    Trop Dis Bull; 1969 Sep; 66(9):885-95. PubMed ID: 4898347
    [No Abstract]   [Full Text] [Related]  

  • 24. Dapsone in wheat flour as a possible method of therapy in leprosy. A laboratory report.
    Naik SS; Pandya SS
    Lepr India; 1977 Oct; 49(4):516-20. PubMed ID: 604659
    [No Abstract]   [Full Text] [Related]  

  • 25. [A survey for school screening in Senegal: considerations on the usefulness of this screening method and on the importance of endemicity among the youthful population of leprosy villages].
    Millan J; Sanokho A; Camara M; Pangou D
    Acta Leprol; 1986; 4(1):37-49. PubMed ID: 3526793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On simultaneous BCG vaccination and DDS chemoprophylaxis.
    Long ER
    Int J Lepr Other Mycobact Dis; 1969; 37(4):412-5. PubMed ID: 5394261
    [No Abstract]   [Full Text] [Related]  

  • 27. Monitoring the regularity of self administration of dapsone by leprosy patients.
    Kumar A; Balakrishnan S
    Lepr India; 1982 Oct; 54(4):664-70. PubMed ID: 7183832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The future of leprosy in the Dominican Republic: experience with multidrug therapy.
    Martinez Cruz D
    Lepr Rev; 1986; 57 Suppl 3():127-33. PubMed ID: 3573953
    [No Abstract]   [Full Text] [Related]  

  • 29. Follow-up study of pauci-bacillary leprosy on-multi-drug regimen.
    Ramanan R; Manglani PR; Ghorpade A; Bhagoliwal SK
    Indian J Lepr; 1987; 59(1):50-3. PubMed ID: 3611861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
    [No Abstract]   [Full Text] [Related]  

  • 31. Operational study to monitor the regularity of dapsone intake by leprosy out-patients.
    Kumar A; Balakrishnan S
    Lepr India; 1983 Jul; 55(3):521-7. PubMed ID: 6656209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regularity of dapsone intake by leprosy patients attending urban treatment centre.
    Naik SS; Ganapati R
    Lepr India; 1977 Apr; 49(2):207-15. PubMed ID: 909287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fixed duration MDT in paucibacillary leprosy.
    Mathai R; George S; Jacob M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):237-41. PubMed ID: 2071980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation and relapse in bacterio-negative cases of leprosy under sulphone therapy: a 4 1/2 years follow-up.
    Neelan PN
    Lepr India; 1976 Oct; 48(4 Suppl):661-7. PubMed ID: 1026801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter: Dapsone dosage and drug resistance.
    Pfaltzgraff RE
    Lepr Rev; 1975 Sep; 46(3):235-8. PubMed ID: 1186417
    [No Abstract]   [Full Text] [Related]  

  • 36. [Suspicion of paucibacillary leprosy resistant to dapsone: importance of follow-up].
    Husser JA; Pattyn SR
    Acta Leprol; 1987; 5(2):147-50. PubMed ID: 3303807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of infection in leprosy.
    Figueredo N; Balkrishnan V
    Lepr Rev; 1967 Apr; 38(2):87-96. PubMed ID: 6045744
    [No Abstract]   [Full Text] [Related]  

  • 38. [Epidemiology of leprosy in Guadalupe between 1970 and 1983].
    Cartel JL; Naudillon Y; Artus JC; Grosset JH
    Bol Oficina Sanit Panam; 1985 Jun; 98(6):535-47. PubMed ID: 3160362
    [No Abstract]   [Full Text] [Related]  

  • 39. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and bacteriological assessment 8 years after triple-drug therapy for multibacillary leprosy in Senegal].
    Dousset-Faure I; Millan J; Decazes JM; Languillon J
    Acta Leprol; 1986; 4(4):465-72. PubMed ID: 3296618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.